Merighi, S.; Borea, P.A.; Varani, K.; Vincenzi, F.; Travagli, A.; Nigro, M.; Pasquini, S.; Suresh, R.R.; Kim, S.W.; Volkow, N.D.;
et al. Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease. Molecules 2022, 27, 2680.
https://doi.org/10.3390/molecules27092680
AMA Style
Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND,
et al. Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease. Molecules. 2022; 27(9):2680.
https://doi.org/10.3390/molecules27092680
Chicago/Turabian Style
Merighi, Stefania, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, Alessia Travagli, Manuela Nigro, Silvia Pasquini, R. Rama Suresh, Sung Won Kim, Nora D. Volkow,
and et al. 2022. "Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease" Molecules 27, no. 9: 2680.
https://doi.org/10.3390/molecules27092680
APA Style
Merighi, S., Borea, P. A., Varani, K., Vincenzi, F., Travagli, A., Nigro, M., Pasquini, S., Suresh, R. R., Kim, S. W., Volkow, N. D., Jacobson, K. A., & Gessi, S.
(2022). Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease. Molecules, 27(9), 2680.
https://doi.org/10.3390/molecules27092680